| Pitavastatin to prevent cardiovascular disease in HIV infection SK Grinspoon, KV Fitch, MV Zanni, CJ Fichtenbaum, T Umbleja, JA Aberg, ... New England Journal of Medicine 389 (8), 687-699, 2023 | 222 | 2023 |
| Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1–infected women EM Kojic, M Kang, MS Cespedes, T Umbleja, C Godfrey, RT Allen, ... Clinical infectious diseases 59 (1), 127-135, 2014 | 201 | 2014 |
| Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity S Bhasin, RA Parker, F Sattler, R Haubrich, B Alston, T Umbleja, ... The Journal of Clinical Endocrinology & Metabolism 92 (3), 1049-1057, 2007 | 130 | 2007 |
| Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084 SE Cohn, T Umbleja, J Mrus, AD Bardeguez, JW Andersen, MA Chesney AIDS Patient Care and STDs 22 (1), 29-40, 2008 | 57 | 2008 |
| Smoking and associated factors among adolescents in Tallinn, Helsinki and Moscow: a multilevel analysis K Pärna, K Rahu, K Fischer, H Mussalo-Rauhamaa, I Zhuravleva, ... Scandinavian journal of public health 31 (5), 350-358, 2003 | 56 | 2003 |
| Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis T Laisaar, V Palmiste, T Vooder, T Umbleja Interactive CardioVascular and Thoracic Surgery 5 (3), 307-310, 2006 | 46 | 2006 |
| Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220 ET Overton, M Kang, MG Peters, T Umbleja, BL Alston-Smith, B Bastow, ... Vaccine 28 (34), 5597-5604, 2010 | 43 | 2010 |
| Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double … K Mulligan, R Zackin, JH Von Roenn, MA Chesney, MJ Egorin, FR Sattler, ... The Journal of Clinical Endocrinology & Metabolism 92 (2), 563-570, 2007 | 39 | 2007 |
| As-needed vs immediate etoposide chemotherapy in combination with antiretroviral therapy for mild-to-moderate AIDS-associated Kaposi sarcoma in resource-limited settings: A5264 … MC Hosseinipour, M Kang, SE Krown, A Bukuru, T Umbleja, JN Martin, ... Clinical Infectious Diseases 67 (2), 251-260, 2018 | 35 | 2018 |
| Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C) KE Sherman, JW Andersen, AA Butt, T Umbleja, B Alston, MJ Koziel, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (5), 597-605, 2010 | 34 | 2010 |
| Initiation of ART is associated with bone loss independent of the specific ART regimen: results of ACTG A5005s P Tebas, T Umbleja, MP Dube, R Parker, K Mulligan, R Roubenoff 14th Conference on Retroviruses and Opportunistic Infections 837, 2007 | 33 | 2007 |
| Cardiovascular risk and health among people with human immunodeficiency virus (HIV) eligible for primary prevention: insights from the REPRIEVE trial PS Douglas, T Umbleja, GS Bloomfield, CJ Fichtenbaum, MV Zanni, ... Clinical Infectious Diseases 73 (11), 2009-2022, 2021 | 31 | 2021 |
| Physical function impairment and frailty in middle-aged people living with human immunodeficiency virus in the REPRIEVE trial ancillary study PREPARE T Umbleja, TT Brown, ET Overton, HJ Ribaudo, JA Schrack, KV Fitch, ... The Journal of Infectious Diseases 222 (Supplement_1), S52-S62, 2020 | 29 | 2020 |
| Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals DD Anthony, T Umbleja, JA Aberg, M Kang, K Medvik, MM Lederman, ... Vaccine 29 (19), 3558-3563, 2011 | 27 | 2011 |
| Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis D Bhattacharya, T Umbleja, F Carrat, RT Chung, MG Peters, F Torriani, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 170-175, 2010 | 27 | 2010 |
| Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1 MS Cespedes, M Kang, EM Kojic, T Umbleja, C Godfrey, ... Papillomavirus Research 6, 15-21, 2018 | 23 | 2018 |
| The incidence, predictors and management of anaemia and its association with virological response in HCV/HIV coinfected persons treated with long‐term pegylated interferon alfa … AA Butt, T Umbleja, JW Andersen, RT Chung, KE Sherman, ... Alimentary pharmacology & therapeutics 33 (11), 1234-1244, 2011 | 23 | 2011 |
| Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial MT Lu, H Ribaudo, B Foldyna, MV Zanni, T Mayrhofer, J Karady, J Taron, ... JAMA cardiology 9 (4), 323-334, 2024 | 22 | 2024 |
| Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in hepatitis C Virus/HIV–coinfected persons: the AIDS Clinical Trials Group A5178 … AA Butt, T Umbleja, JW Andersen, KE Sherman, RT Chung, ... Clinical infectious diseases 55 (5), 631-638, 2012 | 21 | 2012 |
| Immunogenicity and safety of hepatitis B virus (HBV) vaccine with a toll-like receptor 9 agonist adjuvant in HBV vaccine-naïve people with human immunodeficiency virus KM Marks, M Kang, T Umbleja, A Avihingsanon, P Sugandhavesa, ... Clinical Infectious Diseases 77 (3), 414-418, 2023 | 20 | 2023 |
